Blackstone (BX) is planning to secure an $800M loan to finance its acquisition of a stake in a 50-story office building at ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Helmed by Roche alums, Newleos Therapeutics is taking over four drugs dropped from the Swiss pharma’s pipeline in early 2024.

Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...